United States · Bill · S
S. 1723 (117th)
Budgeting for Opioid Addiction Treatment Act
Introduced
20 May 2021
Last action
—
Status
Read twice and referred to the Committee on Finance.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Budgeting for Opioid Addiction Treatment Act This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof. The bill provides block grants for substance abuse treatment programs. The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 20 May 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 20 May 2021
Introduced in Senate
summary · EN · 20 May 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/1723
- Open data entity: https://api.congress.gov/v3/bill/117/s/1723